OTCMKTS:DIGP

Digipath (DIGP) Stock Forecast, Price & News

$0.02

+0.00 (+5.56%)

(As of 05/18/2022 03:32 PM ET)

Add

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.01
▼
$0.03
52-Week Range: $0.01
▼
$0.09

Volume: 13,060 shs
Average Volume: 285,512 shs
Market Capitalization: $1.43 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 1.15

30 days | 90 days | 365 days | Advanced Chart

Receive DIGP News and Ratings via Email

Sign-up to receive the latest news and ratings for Digipath and its competitors with MarketBeat's FREE daily newsletter.

About Digipath

Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

May 2, 2022 | finance.yahoo.com

Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus

April 4, 2022 | msn.com

Digipath To Test Redwood Cultivation Products, Including Mike Tyson's Ear Shaped Cannabis Gummies

April 4, 2022 | seekingalpha.com

Digipath to provide product testing for Redwood Cultivation Products

April 4, 2022 | finance.yahoo.com

Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson’s New Ear Shaped Gummies, ‘Mike Bites’

March 1, 2022 | benzinga.com

Digipath Teams Up With CASPR Technologies To Determine Efficacy For New Anti-Microbial Product For Cannabis Industry

March 1, 2022 | finance.yahoo.com

Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry

February 15, 2022 | msn.com

Digipath Reports Substantial Sequential Growth In Gross Profit & Revenue In Q1

February 15, 2022 | finance.yahoo.com

Digipath Announces Financial Results for Q1, 2022

February 9, 2022 | finance.yahoo.com

Digipath Obtains Coveted Compliance Testing License for California Laboratory

January 4, 2022 | finance.yahoo.com

Digipath Announces Results for the Fiscal Year 2021

December 7, 2021 | finance.yahoo.com

EVIO Inc. Executes Letter of Intent to sell C3 Labs, LLC to Digipath, Inc.

December 7, 2021 | finance.yahoo.com

Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill’s Licensed Northern California Lab from Evio Labs

December 6, 2021 | finance.yahoo.com

Digipath, Inc. to Present at the Emerging Growth Conference on Wednesday, December 8th at 12n EST/ 9:00 am PST

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Management consulting services
Sub-Industry: Cannabis
Sector: Medical
Current Symbol: OTCMKTS:DIGP
Previous Symbol
CUSIP: N/A
CIK: 1502966
Web: www.digipath.com
Phone: (702) 527-2060
Fax: N/A
Employees: 17
Year Founded: N/A

Sales & Book Value

Annual Sales: $2.50 million
Price / Sales: 0.57
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.01) per share
Price / Book: -1.90

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: $-690 thousand
Net Margins: -21.68%
Pretax Margin: -21.68%
Return on Equity: N/A
Return on Assets: -33.14%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.46
Quick Ratio: 0.46

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 75,150,000
Free Float: 67,031,000
Market Cap: $1.43 million
Optionable: Not Optionable

Company Calendar

Last Earnings: 8/13/2019
Today: 5/19/2022
Fiscal Year End: 9/30/2022

MarketRank^™

Overall MarketRank^™

1.05 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Digipath.

4.4 Community Rank

Outperform Votes
Digipath has received 55 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Digipath has received 28 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Digipath has received 66.27% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Digipath and other stocks. Vote “Outperform” if you believe DIGP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DIGP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Digipath does not currently pay a dividend.
Dividend Growth
Digipath does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Digipath insiders have not sold or bought any company stock.
Percentage Held by Insiders
10.80% of the stock of Digipath is held by insiders. A high percentage of insider ownership can be a sign of company health.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Digipath (OTCMKTS:DIGP) Frequently Asked Questions

How were Digipath's earnings last quarter?: Digipath, Inc. (OTCMKTS:DIGP) announced its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.01) EPS for the quarter. The firm earned $0.65 million during the quarter.
View Digipath's earnings history.
Who are Digipath's key executives?: Digipath's management team includes the following people:
Mr. Todd Denkin, Founder & Pres (Age 58, Pay $198k)
Mr. A. Stone Douglass, Chairman, CFO & Sec. (Age 74)
Dr. Drazen M. Jukic M.D., Ph.D., Exec. Officer
Mr. Bo Deitl, Consultant
Who are some of Digipath's key competitors?: Some companies that are related to Digipath include Innovative Industrial Properties (IIPR), Canopy Growth (WEED), MassRoots (MSRT), Cronos Group (MJN), CanniMed Therapeutics (CMED), OrganiGram (OGI), GrowGeneration (GRWG), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Bioventix (BVXP), Maple Leaf Green World (MGW), KushCo (KSHB) and Net Savings Link (NSAV).
View all of DIGP's competitors.
What other stocks do shareholders of Digipath own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Digipath investors own include Freedom Leaf (FRLF), AT&T (T), BP (BP), GrowGeneration (GRWG), KushCo (KSHB), Lumen Technologies (LUMN), AdvisorShares Pure US Cannabis ETF (MSOS), Rocky Mountain High Brands (RMHB), Unrivaled Brands (TRTC) and Agritek (AGTK).
What is Digipath's stock symbol?: Digipath trades on the OTCMKTS under the ticker symbol "DIGP."
How do I buy shares of Digipath?: Shares of DIGP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Digipath's stock price today?: One share of DIGP stock can currently be purchased for approximately $0.02.
How much money does Digipath make?: Digipath has a market capitalization of $1.43 million and generates $2.50 million in revenue each year.
How many employees does Digipath have?: Digipath employs 17 workers across the globe.
What is Digipath's official website?: The official website for Digipath is www.digipath.com.
How can I contact Digipath?: Digipath's mailing address is 6450 CAMERON STREET SUITE 113, LAS VEGAS NV, 89118. The company can be reached via phone at (702) 527-2060 or via email at [email protected].

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.